Chapter RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• Future directions
• Future directions in liver replacement therapy: Liver xenotransplantation
• Future therapy of IBD
• G
• Gastrointestinal bleeding
• Gastrointestinal Complications of the Acquired Immunodeficiency Syndrome
• Gastrointestinal Complications of the Acquired Immunodeficiency Syndrome
• Gastrointestinal Complications of the Acquired Immunodeficiency Syndrome
• Gastrointestinal Complications of the Acquired Immunodeficiency Syndrome
• Gastrointestinal Diseases with an Immune Basis
• Gastrointestinal Diseases with an Immune Basis
• Gastrointestinal diseases with an immune origin
• Gastrointestinal hormones
• Gastrointestinal Infections in HIV-1 Disease
• Gastrointestinal Manifestations of Rheumatoid Arthritis
• Gastrointestinal peptides
• Gastrointestinal peptides
• Gender dimorphism and the use of sex steroid/receptor antagonist after trauma
• Gene therapy and immune senescence
• Gene Therapy for Myocardial Protection
• Gene therapy in the treatment of human cancer
• Gene-environment interaction.
• Gene-environment Interactions: Gene-environment interactions in human traits
• General approach to poisoning
• General Considerations Concerning Safety in Biomedical Research Laboratories
• General pathophysiology of neuroglia: Neurological and psychiatric disorders as gliopathies
• General principles of mastectomy: Evaluation and therapeutic options
• Genetic and chemical models of IBD. In Proc. of Falk Symposium No. 96
• Genetic and Molecular Buffering of Phenotypes
• Genetic Counseling and Clinical Risk Assessment

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...